Flagship Pioneering Fund VII General Partner LLC
- SEC CIK
- 0001805917
No open-market purchases or sales filed in the past year.
Current role at each company
- GENB Generate Biomedicines, Inc.10% Owneras of Mar 2, 2026
- FHTX Foghorn Therapeutics Inc.Director, 10% Owneras of Jan 15, 2026
- EVLO Evelo Biosciences, Inc.10% Owneras of Jul 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Flagship Pioneering Fund VII General Partner LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
GENB Generate Biomedicines, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 (view filing)5:52 PM ET | Mar 2 | Same day | Afeyan Noubar and 7 othersDirector, 10% Owner | PPurchase | +4.69M | $16.00 | +$75.0M | New position1.56M after | 3 lotsDuplicate filing |
EVLO Evelo Biosciences, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2023 (view filing)5:15 PM ET | Jul 11 | 2 days | Afeyan Noubar and 7 others10% Owner | PPurchase | +5.41M | $2.31 | +$12.5M | New position3.93M after | 3 lots |